BUZZ-蒙地罗萨公司因心脏药物在早期试验中显示出前景而上涨

路透中文
Jan 07
BUZZ-蒙地罗萨公司因心脏药物在早期试验中显示出前景而上涨

1月7日 - ** 药物开发商Monte Rosa Therapeutics GLUE.O股价盘前上涨18.6%至19美元

** 该公司称其实验性药物MRT-8102在一项早期试验中大幅降低了心脏病高危人群的炎症反应

** 公司表示,其 MRT-8102 能将高危患者的炎症指标 CRP 降低 85

** CRP 与心脏病有关;几乎所有参与者在 4 周后都达到了安全水平 - GLUE

** 公司称,研究招募了 24 名肥胖和 CRP 升高的患者;药物在所有剂量下都有效

** 公司计划今年晚些时候在动脉堵塞患者中开展更大规模的试验 - GLUE

** 截至上次收盘,股价在过去一年中上涨了 ~2

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10